Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Miller

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
The Lancet. Neurology|July 11, 2014
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imagingOlga Ciccarelli, Frederik Barkhof, Benedetta Bodini, et al.
The New England Journal of Medicine|January 26, 2007
Lack of association between antimyelin antibodies and progression to multiple sclerosisJens Kuhle, Christoph Pohl, Matthias Mehling, et al.
The Lancet. Neurology|July 10, 2007
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective studyJosephine K Swanton, Alex Rovira, Mar Tintore, et al.
Annals of Neurology|April 5, 2013
Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis opticaOlga Ciccarelli, David L Thomas, Enrico De Vita, et al.
The New England Journal of Medicine|March 3, 2006
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosisChris H Polman, Paul W O'Connor, Eva Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2012
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosisIris-Katharina Penner, Brigitte Stemper, Pasquale Calabrese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosisMarco Rovaris, Elda Judica, Jaume Sastre-Garriga, et al.
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
The Lancet. Neurology|July 11, 2014
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imagingOlga Ciccarelli, Frederik Barkhof, Benedetta Bodini, et al.
The New England Journal of Medicine|January 26, 2007
Lack of association between antimyelin antibodies and progression to multiple sclerosisJens Kuhle, Christoph Pohl, Matthias Mehling, et al.
The Lancet. Neurology|July 10, 2007
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective studyJosephine K Swanton, Alex Rovira, Mar Tintore, et al.
Annals of Neurology|April 5, 2013
Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis opticaOlga Ciccarelli, David L Thomas, Enrico De Vita, et al.
The New England Journal of Medicine|March 3, 2006
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosisChris H Polman, Paul W O'Connor, Eva Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2012
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosisIris-Katharina Penner, Brigitte Stemper, Pasquale Calabrese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosisMarco Rovaris, Elda Judica, Jaume Sastre-Garriga, et al.
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Pageof 22